212 related articles for article (PubMed ID: 12582431)
1. [Study of the susceptibility of black yeasts of the Exophiala genus to antifungals using the Sensititre System].
Puerto JL; García-Martos P; Marín P; Sepúlveda A; García-Agudo R; Aoufi S
Rev Esp Quimioter; 2002 Sep; 15(3):268-71. PubMed ID: 12582431
[TBL] [Abstract][Full Text] [Related]
2. In vitro activities of five antifungal agents against pathogenic Exophiala species.
Li D; Li R; Wang D; Ma S
Chin Med J (Engl); 1999 Jun; 112(6):484-8. PubMed ID: 11601322
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Vivas JR; Torres-Rodríguez JM
Rev Esp Quimioter; 2001 Jun; 14(2):191-7. PubMed ID: 11704774
[TBL] [Abstract][Full Text] [Related]
4. Exoantigen test for the rapid identification of Exophiala spinifera.
Standard PG; Padhye AA; Kaufman L
J Med Vet Mycol; 1991; 29(4):273-7. PubMed ID: 1719180
[TBL] [Abstract][Full Text] [Related]
5. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
[TBL] [Abstract][Full Text] [Related]
6. Identification, classification, and phylogeny of the pathogenic species Exophiala jeanselmei and related species by mitochondrial cytochrome b gene analysis.
Wang L; Yokoyama K; Miyaji M; Nishimura K
J Clin Microbiol; 2001 Dec; 39(12):4462-7. PubMed ID: 11724862
[TBL] [Abstract][Full Text] [Related]
7. Species diversity, antifungal susceptibility and phenotypic and genotypic characterisation of Exophiala spp. infecting patients in different medical centres in Brazil.
Silva WC; Gonçalves SS; Santos DW; Padovan AC; Bizerra FC; Melo AS
Mycoses; 2017 May; 60(5):328-337. PubMed ID: 28139861
[TBL] [Abstract][Full Text] [Related]
8. [Antifungal susceptibility of Acremonium species using E-test and Sensititre].
Saldarreaga A; Garcia Martos P; Ruiz Aragón J; García Agudo L; Montes de Oca M; Puerto JL; Marín P
Rev Esp Quimioter; 2004 Mar; 17(1):44-7. PubMed ID: 15201923
[TBL] [Abstract][Full Text] [Related]
9. [Yeasts in domestic animals: species identification and susceptibility to antifungals].
Hamal P; Koukalová D
Klin Mikrobiol Infekc Lek; 2010 Feb; 16(1):4-9. PubMed ID: 20401831
[TBL] [Abstract][Full Text] [Related]
10. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist.
Badali H; de Hoog GS; Sudhadham M; Meis JF
Med Mycol; 2011 Nov; 49(8):819-24. PubMed ID: 21612562
[TBL] [Abstract][Full Text] [Related]
11. In vitro activities of antifungal drugs against environmental Exophiala isolates and review of the literature.
Gülmez D; Doğan Ö; Boral B; Döğen A; İlkit M; de Hoog GS; Arikan-Akdagli S
Mycoses; 2018 Aug; 61(8):561-569. PubMed ID: 29611230
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Vitale RG; Afeltra J; de Hoog GS; Rijs AJ; Verweij PE
J Antimicrob Chemother; 2003 May; 51(5):1297-300. PubMed ID: 12697648
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of antifungal drugs, as well as drug combinations against Exophiala dermatitidis.
Sun Y; Liu W; Wan Z; Wang X; Li R
Mycopathologia; 2011 Feb; 171(2):111-7. PubMed ID: 20803255
[TBL] [Abstract][Full Text] [Related]
14. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species.
Badali H; Najafzadeh MJ; van Esbroeck M; van den Enden E; Tarazooie B; Meis JF; de Hoog GS
Med Mycol; 2010 Mar; 48(2):318-27. PubMed ID: 19642051
[TBL] [Abstract][Full Text] [Related]
15. In vitro activities of 8 antifungal drugs against 126 clinical and environmental Exophiala isolates.
Najafzadeh MJ; Dolatabadi S; Vicente VA; de Hoog GS; Meis JF
Mycoses; 2021 Nov; 64(11):1328-1333. PubMed ID: 34411353
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test].
Buchta V; Navrátilová L; Förstl M; Kubanová P
Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Vitale RG; De Hoog GS; Verweij PE
Med Mycol; 2003 Aug; 41(4):301-7. PubMed ID: 12964723
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial DNA analysis of Exophiala jeanselmei var. lecanii-corni and Exophiala castellanii.
Kawasaki M; Ishizaki H; Matsumoto T; Matsuda T; Nishimura K; Miyaji M
Mycopathologia; 1999; 146(2):75-7. PubMed ID: 10822506
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous phaeohyphomycosis caused by Exophiala spinifera in a patient with systemic lupus erythematosus.
Lin YP; Li W; Yang YP; Huang WM; Fan YM
Lupus; 2012 Apr; 21(5):548-51. PubMed ID: 22065094
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
Martín-Mazuelos E; Pemán J; Valverde A; Chaves M; Serrano MC; Cantón E
J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
